Article by Anisha Dhiman, London Free Press
With skyrocketing sales among stockpilers, cannabis in the time of coronavirus is under the spotlight. Now, a team of researchers from the University of Miami wants to know how cannabis consumption is being impacted by COVID-19.
In addition to surveying recreational consumers, researchers are particularly interested in medical cannabis consumers. Many fall under the high-risk category when it comes to coronavirus because of compromised immune systems or underlying medical conditions.
“The global qualifying conditions for medical cannabis, though not uniform, all include individuals with compromised immune systems and other chronic health conditions,” said Denise C. Vidot, an assistant professor in the School of Nursing and Health Studies and a trained epidemiologist, who is leading the research. “This is a population that we cannot forget about in our joint effort to flatten the curve.”